FibroBiologics Presents Preclinical Data at the 2022 Consortium of Multiple Sclerosis Centers Annual Meeting
- Tuesday, May 31, 2022, 8:22
- Business
- Add a comment
HOUSTON, May 31, 2022 /PRNewswire/ — FibroBiologics, a clinical-stage biotechnology company developing fibroblast-based therapeutic cures for chronic diseases, will present preclinical and safety-centered limited clinical trial data for the single-dose infusion of tolerogenic human…
About the Author
adminasapcorp has written 37667 stories on this site.